232 related articles for article (PubMed ID: 32702129)
1. Associations of Serum Pepsinogens and Helicobacter Pylori Infection with High-Sensitivity C-Reactive Protein in Medical Examination Population.
Liu H; Fei C; Zhang J
Lab Med; 2021 Jan; 52(1):57-63. PubMed ID: 32702129
[TBL] [Abstract][Full Text] [Related]
2. Serum Pepsinogen Levels Are Correlated With Age, Sex and the Level of Helicobacter pylori Infection in Healthy Individuals.
Huang RG; Xiao HL; Zhou B; Song XH; Zhang J; Wang CM; Jiang YH; Chen DZ; Huang B
Am J Med Sci; 2016 Nov; 352(5):481-486. PubMed ID: 27865295
[TBL] [Abstract][Full Text] [Related]
3. Changes with aging in gastric biomarkers levels and in biochemical factors associated with
Shan JH; Bai XJ; Han LL; Yuan Y; Sun XF
World J Gastroenterol; 2017 Aug; 23(32):5945-5953. PubMed ID: 28932086
[TBL] [Abstract][Full Text] [Related]
4. [Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis].
Chae H; Lee JH; Lim J; Kim M; Kim Y; Han K; Kang CS; Shim SI; Kim JI; Park SH
Korean J Lab Med; 2008 Jun; 28(3):201-6. PubMed ID: 18594172
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori infection, serum pepsinogens, and pediatric abdominal pain: a pilot study.
Kassem E; Naamna M; Mawassy K; Beer-Davidson G; Muhsen K
Eur J Pediatr; 2017 Aug; 176(8):1099-1105. PubMed ID: 28681188
[TBL] [Abstract][Full Text] [Related]
6. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study.
Gisbert JP; Boixeda D; Al-Mostafa A; Vila T; de Rafael L; Alvarez Baleriola I; de Argila CM; Abraira V
Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):189-200. PubMed ID: 10102232
[TBL] [Abstract][Full Text] [Related]
7. Association between abnormal gastric function risk and Helicobacter pylori infection assessed by ELISA and 14C-urea breath test.
Gong Y; Wei W; Yuan Y
Diagn Microbiol Infect Dis; 2014 Dec; 80(4):316-20. PubMed ID: 25284372
[TBL] [Abstract][Full Text] [Related]
8. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
[TBL] [Abstract][Full Text] [Related]
9. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.
Leja M; Cine E; Rudzite D; Vilkoite I; Huttunen T; Daugule I; Rumba-Rozenfelde I; Pimanov S; Liepniece-Karele I; Pahomova J; Purmalis K; Eglitis J; Pirags V; Dzerve V; Erglis A
Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1410-7. PubMed ID: 23114744
[TBL] [Abstract][Full Text] [Related]
11. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
Kiyohira K; Yoshihara M; Ito M; Haruma K; Tanaka S; Chayama K
J Gastroenterol; 2003; 38(4):332-8. PubMed ID: 12743772
[TBL] [Abstract][Full Text] [Related]
12. Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects.
Yu H; Liu Y; Jiang S; Zhou Y; Guan Z; Dong S; Chu FF; Kang C; Gao Q
Medicine (Baltimore); 2021 Jul; 100(27):e26562. PubMed ID: 34232200
[TBL] [Abstract][Full Text] [Related]
13. Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis.
Nasrollahzadeh D; Aghcheli K; Sotoudeh M; Shakeri R; Persson EC; Islami F; Kamangar F; Abnet CC; Boffetta P; Engstrand L; Dawsey SM; Malekzadeh R; Ye W
PLoS One; 2011; 6(10):e26957. PubMed ID: 22066020
[TBL] [Abstract][Full Text] [Related]
14. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
[TBL] [Abstract][Full Text] [Related]
15. Relationship among serum pepsinogens, serum gastrin, gastric mucosal histology and H. pylori virulence factors in a paediatric population.
Lopes AI; Palha A; Lopes T; Monteiro L; Oleastro M; Fernandes A
Scand J Gastroenterol; 2006 May; 41(5):524-31. PubMed ID: 16638693
[TBL] [Abstract][Full Text] [Related]
16. Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study.
Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Long Q; Flanders WD; Bostick RM; Yuan Y
Int J Cancer; 2015 Jan; 136(2):425-34. PubMed ID: 24895149
[TBL] [Abstract][Full Text] [Related]
17. Long-term dynamics of gastric biomarkers after eradication of Helicobacter pylori infection.
Daugule I; Ruskule A; Moisejevs G; Rudzite D; Jonaitis L; Janciauskas D; Kiudelis G; Kupcinskas L; Leja M
Eur J Gastroenterol Hepatol; 2015 May; 27(5):501-5. PubMed ID: 25822857
[TBL] [Abstract][Full Text] [Related]
18. Follow-up study on a high risk population of gastric cancer in north China by serum pepsinogen assay.
Sun LP; Gong YH; Wang L; Gong W; Yuan Y
J Dig Dis; 2008 Feb; 9(1):20-6. PubMed ID: 18251790
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
Al-Assi MT; Miki K; Walsh JH; Graham DP; Asaka M; Graham DY
Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
[TBL] [Abstract][Full Text] [Related]
20. Examination of serum pepsinogen in functional dyspepsia.
Tahara T; Shibata T; Okubo M; Yamashita H; Yoshioka D; Yonemura J; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Yamada H; Nakamura M; Arisawa T; Hirata I
Hepatogastroenterology; 2012; 59(120):2516-22. PubMed ID: 23178618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]